Adagene Inc. (ADAG)
Develops antibody drugs to treat cancer patients in China.
$3.73+0.06%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+94.3%
The outlook
Adagene trades at $3.73 with six analysts issuing a Strong Buy consensus. The stock sits roughly two-thirds of the way between its 52-week low and high, showing mixed momentum against its moving averages. Analysts' average price target sits approximately 188% above the current price.
What’s behind the score
Analyst consensusStrong Buy — 1.3 avg of 6 analysts
Price trendMixed vs its moving averages
52-week range68% of the way from its 52-week low to high
Price targetAvg target +188% vs current price
Analyst price target
~12-month · 6 analysts$10.74average target+188.0% vs now
Now $3.73
Low $7.00High $17.45
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$246.5M
52-wk high
$4.85
52-wk low
$1.30
50-day avg
$3.73
200-day avg
$2.93
Trailing P/E
—